Zhixiang Chen

5PUBLICATIONS
22CO-AUTHORS
Predictive and prognostic markersElectrochemical energy storage and conversionHealth and ecological risk assessmentMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 03, 2025
Targeting histone H2B acetylated enhanceosomes via p300/CBP degradation in prostate cancer.

Jie Luo, Zhixiang Chen, Yuanyuan Qiao

|May 01, 2025
Development of PVTX-405 as a potent and highly selective molecular glue degrader of IKZF2 for cancer immunotherapy.

Zhixiang Chen, Harshil Dhruv, Xuqing Zhang

|Apr 08, 2025
Correction to "Discovery of ERD-1233 as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader for the Treatment of ER+ Human Breast Cancer".

Ranjan Kumar Acharyya, Rohan Kalyan Rej, Biao Hu

|Nov 25, 2024
Discovery of ERD-12310A as an Exceptionally Potent and Orally Efficacious PROTAC Degrader of Estrogen Receptor α (ERα).

Rohan Kalyan Rej, Biao Hu, Zhixiang Chen

|Nov 01, 2024
Discovery of ERD-1233 as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader for the Treatment of ER+ Human Breast Cancer.

Ranjan Kumar Acharyya, Rohan Kalyan Rej, Biao Hu

Pageof 1

Frequent Collaborators

5 joint publications

Shaomeng Wang

4 joint publications

Rohan Kalyan Rej

4 joint publications

E Scott Priestley

4 joint publications

Duxin Sun